Rooted in two decades of scientific progress, CELFULL's platform integrates three core pillars:
Aging is a natural process characterized by the accumulation of damages and decline of biological functions over time, affecting every cell, tissue, organ, and system in the body. This leads to increased susceptibility to diseases and mortality.
CELFULL aims to understand the fundamental biology of aging, discover the secrets of longevity and vitality, and translate this knowledge into aging-intervention solutions that extend healthspan and lifespan.
CELFULL combines artificial intelligence with aging biology, conducting aging and multi-target aging intervention research. Our core technologies include artificial intelligence network pharmacology, systems biology, and computer-aided drug design. We aim to advance anti-aging research towards personalization, precision, and intelligence, aspiring to become a world-leading AI-driven aging intervention research and development and application platform.
We always insist on understanding the cell biology that controls aging, and we want to use that knowledge to develop interventions that enable people to live longer, healthier and fuller lives.
Aging research is a multidisciplinary and collaborative field that integrates expertise from diverse disciplines such as medicine, biology, chemistry, physics, and engineering. Our scientists have made significant breakthroughs in these areas and have published their findings in renowned, peer-reviewed journals.
